NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation
Authors
Keywords
Leukemia, Zebrafish, SH2 domains, Cancer treatment, Cell proliferation, Cell metabolism, Protein domains, Bone marrow cells
Journal
PLoS One
Volume 15, Issue 8, Pages e0236839
Publisher
Public Library of Science (PLoS)
Online
2020-08-12
DOI
10.1371/journal.pone.0236839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using zebrafish models of leukemia to streamline drug screening and discovery
- (2017) Adam P. Deveau et al. EXPERIMENTAL HEMATOLOGY
- Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
- (2016) Gianantonio Rosti et al. Nature Reviews Clinical Oncology
- Hematopoietic stem cells: concepts, definitions, and the new reality
- (2015) C. J. Eaves BLOOD
- The Capable ABL: What Is Its Biological Function?
- (2014) J. Y. J. Wang MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers
- (2014) Ichiro Maruyama Cells
- The Multifaceted Functions of Neutrophils
- (2013) Tanya N. Mayadas et al. Annual Review of Pathology-Mechanisms of Disease
- Transition metal free hydrolysis/cyclization strategy in a single pot: synthesis of fused furo N-heterocycles of pharmacological interest
- (2013) Ali Nakhi et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: A one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents
- (2012) K. Shiva Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Zebrafish screen identifies novel compound with selective toxicity against leukemia
- (2012) S. Ridges et al. BLOOD
- Cu-Catalyzed Reaction of 1,2-Dihalobenzenes with 1,3-Cyclohexanediones for the Synthesis of 3,4-Dihydrodibenzo[b,d]furan-1(2H)-ones
- (2012) Nayyef Aljaar et al. JOURNAL OF ORGANIC CHEMISTRY
- Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036
- (2011) Wayne W. Chan et al. CANCER CELL
- Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists
- (2010) Nigus D. Ambaye et al. BIOORGANIC & MEDICINAL CHEMISTRY
- In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days
- (2010) J. Pillay et al. BLOOD
- Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia
- (2010) T. O'Hare et al. CLINICAL CANCER RESEARCH
- Docking proteins
- (2010) Tilman Brummer et al. FEBS Journal
- A Chemical Genetic Screen in Zebrafish for Pathways Interacting with cdx4 in Primitive Hematopoiesis
- (2010) Elizabeth J. Paik et al. Zebrafish
- Zebrafish kidney stromal cell lines support multilineage hematopoiesis
- (2009) D. L. Stachura et al. BLOOD
- Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation
- (2009) Jing-Ruey J Yeh et al. Nature Chemical Biology
- Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
- (2008) Stuart H. Orkin et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started